Last reviewed · How we verify
Placebo to match asenapine — Competitive Intelligence Brief
phase 3
Psychiatry
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo to match asenapine (Placebo to match asenapine) — Organon and Co. This is an inert placebo formulation designed to match the physical and sensory characteristics of asenapine for blinded clinical trial comparisons.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo to match asenapine TARGET | Placebo to match asenapine | Organon and Co | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo to match asenapine CI watch — RSS
- Placebo to match asenapine CI watch — Atom
- Placebo to match asenapine CI watch — JSON
- Placebo to match asenapine alone — RSS
Cite this brief
Drug Landscape (2026). Placebo to match asenapine — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-to-match-asenapine. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab